thumbnail image
broken image
broken image
broken image

UE LifeSciences

  • Innovations 
    • iBreastExam
    • cervAIcal
    • OrCA
    • RaKSA
  • Team & Journey
  • Stay Abreast
  • …  
    • Innovations 
      • iBreastExam
      • cervAIcal
      • OrCA
      • RaKSA
    • Team & Journey
    • Stay Abreast
Contact Us
broken image
broken image
broken image

UE LifeSciences

  • Innovations 
    • iBreastExam
    • cervAIcal
    • OrCA
    • RaKSA
  • Team & Journey
  • Stay Abreast
  • …  
    • Innovations 
      • iBreastExam
      • cervAIcal
      • OrCA
      • RaKSA
    • Team & Journey
    • Stay Abreast
Contact Us
broken image
  • Reshaping Early Detection. For All.

    Trusted by 1.2 Million women globally with hand-held innovations that are truly

    accessible and effective for all

    Our Innovations
  • Rewriting Cancer

    Though Asha didn't show any symptoms, an early screening revealed she had breast cancer. See how an easy-to-use device is helping healthcare workers in India carry out screenings for breast cancer quickly and effectively, giving women a better chance of seeking early treatment. Rewriting Cancer film series is produced for the Union for International Cancer Control by BBC Storyworks and launched at World Cancer Congress 2024.
    broken image
  • Hand-Held Innovations Usable by Community Health Workers

    Non-invasive, Painless & Radiation-Free Tools Require Minimal Training, Work Offline & Offer Instant Results with High Efficacy

    broken image

    iBreastExam

    Extensively Validated Breast Lump Detection

    Learn More
    broken image

    CervAIcal

    Full Featured Mobile Colposcope On The Go

    Learn More
    broken image

    OrCA

    Oral Cancer Assessment

    Learn More
  • Integrating Multi-Cancer Screening

    Single Visit, Breast + Cervical + Oral Examination & Navigation Initiative for Large Scale Implementation

    LEARN MORE
  • Events & Milestones

    MOL PLUS設立4周年のご報告
    April 25, 2025
    『海運業と社会に新しい価値をPLUSする』をミッションに商船三井から立ち上げた、我が社海運CVC『MOL PLUS』は、おかげさまで4月26日(土)で4周年となりまして、5期目に入ります。 ファ...
    Read more...
    投資先のデジタルグリッド株式会社が東証グロース市場に新規上場
    April 23, 2025
    株式会社MOL PLUS(代表:阪本拓也、本社:東京都港区)は、投資先のデジタルグリッド株式会社(代表取締役社長:豊田祐介、本社:東京都港区、以下「デジタルグリッド」)が、2025年4月22日に...
    Read more...
    東京都主催の「東京金融賞2024」サステナビリティ部門にて、海運分野に関する取り組みとして初の受賞
    March 7, 2025
     株式会社商船三井(社長:橋本剛、本社:東京都港区、以下「商船三井」)の100%子会社CVC(コーポレートベンチャーキャピタル)である株式会社MOL PLUS(代表:阪本 拓也、本社:東京都港区...
    Read more...
    More Posts
  • Partners & Collaborators

    Global Leaders. Market Shapers. Impact Makers.

    broken image

    India

    Gov. of India company and the largest health PSU

    broken image

    USA

    World leading player in imaging and diagnostics

    broken image

    Malaysia

    Malaysia's leading pharma company

    broken image

    Colombia

    A leading preventive health company based in Colombia

    broken image

    S Africa

    A leading preventive health company in South Africa

  • Awards & Recognitions

    broken image
    broken image
    broken image
    broken image
    broken image
    broken image
    broken image
  • News & Media

    UE Lifesciences on The New York Times

    Article

    TED Talks Shah Rukh Khan about UE LifeSciences

    Video

    UE LifeSciences on BBC News

    Video

    YourStory UE LifeSciences

    Article

    UE LifeSciences Featured on Forbes

    Article

  • Journey in Numbers

    2 Million+

    breast exams supplied

    500+

    Cancers Detected

    10

    Markets Entered

    $1.7M+

    Grant Awards

    $8.5M

    Capital Raised

    15+

    Awards

  • Contact Us

    You + Us = Awesome

    - Philadelphia (USA)
    - Mumbai, Bangalore, Delhi (India)
    - Kuala Lumpur (Malaysia)
    - Bogota (Colombia)
    USA +1-267-225-0453, India +91-22-26102610, Malaysia +60 3 62063079
    USA +1-267-225-0453, India +91-22-26102610, Malaysia +60 3 62063079
    info@uelifesciences.com

Home

Journey

Team

Newsletter

+1.267.225.0453

info@UELifeSciences.com

iBreastExam

CervAIcal

OrCA

RaKSA

UE LifeSciences Inc. Copyright © 2024 | Terms & Conditions | Privacy Policy

    Home
    Innovation
    Call
    Email
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More